Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6811
Peer-review started: January 13, 2022
First decision: March 16, 2022
Revised: March 17, 2022
Accepted: April 22, 2022
Article in press: April 22, 2022
Published online: July 16, 2022
Processing time: 172 Days and 20.3 Hours
Persistent postural-perceptual dizziness (PPPD) is characterized by a shift in processing spatial orientation information to favor visual or somatosensory information over vestibular inputs as well as failure of higher cortical mechanisms.
To date, no potential therapies for PPPD have been evaluated in randomized controlled clinical trials or been approved as a cure for this condition. Hangebyakujututemmato (HBT) has been reported as a potential treatment for PPPD.
Our aim was to examine the efficacy of HBT in PPPD.
Patients were administered HBT extract (7.5 g/day), or not, for 3 mo. Assessments such as equilibrium tests were performed at baseline and every month after the start of the study. Multivariate regression analysis was performed to identify HBT responders.
The Kampo medicine, HBT, was effective as an adjunctive therapy for PPPD. In addition, HBT responders had autonomic dysfunction, unstable balance, semicircular canal paresis, anxiety, and poor sleep quality at baseline.
HBT may be an effective adjunct treatment for PPPD. We identified the characteristics of the HBT responders.
According to our results, and previous reports, several herbal ingredients in HBT might improve autonomic function and the cyclic AMP response element binding protein/the brain-derived neurotrophic factor pathway, resulting in sensory reweighting to establish a balance between the systems involved in PPPD.